Ergosterol peroxide was isolated from the ethanol extract of Pleurotus eryngii as an inhibitor of osteoclast differentiation. This compound showed an inhibitory effect in a dose-dependent manner and an inhibition rate of up to 62% with low cytotoxicity, even at a concentration as low as 1.0 g/mL.
The king oyster mushroom (Pleurotus eryngii), an edible species, has protective effects on the liver and kidney, aids in gastrointestinal disorders, and has anti-tumor properties [4a] . Based on our previous results on prevention of bone loss [3] , the ethanol extract of P. eryngii was separated into six fractions (Fr. 1 -Fr. 6), which were then used in the osteoclast differentiation assay (Figure1). All fractions, except for Fr. 1, showed the ability for osteoclast differentiation inhibition, and the inhibitory effect increased in proportion to the concentration (data not shown), and reached a maximum at a concentration of 100 g/mL. Accompanied by inhibitory efficiency, however, there was also a tendency for decreased cell viability when the concentration was increased. Of the fractions, Fr. 3 was chosen for further separation because it showed a good balance between differentiation inhibitory ability and cytotoxicity. Although Fr. 3 showed an inhibitory effect of 85%, in comparison with the control, at a concentration of 100 g/mL, all of the separated sub-fractions (Fr. 3-1 to Fr. 3-9) could reach this inhibitory level at a concentration lower than 75 g/mL. Fr. 3-4 even showed a significantly inhibitory effect at a concentration of 1 g/mL, without much toxicity. This result leads us to propose a mutual interaction, which resulted in a decrease of activity of each component, between components inside fractions. However, this hypothesis needs to be confirmed by further studies. Compared with control, except for Fr. 3-9, most of the fractions inhibited the progenitor of differentiation to the mature osteoclast. Surprisingly, there was a tendency for a decrease in activity after fractionation of Fr. 3-4. While the original fraction showed a very high inhibitory activity on osteoclast differentiation at quite a low concentration (1 g/mL), the sub-fractions (Fr. 3-4-1 to Fr. 3-4-3) had a significantly lower differentiation inhibition activity. Even with the most active fraction of the three, and at ten times higher concentration, Fr. 3-4-2 (ergosterol peroxide) could not reach the same inhibitory level as the original fraction. Although the cause of this phenomenon is unclear, there seem to have been interactions that induce either the decrease or increase of activity of the components, as proposed above.
To the best of our knowledge, this is the first time that ergosterol peroxide has been used for an osteoclast differentiation assay. The compound showed an inhibitory effect in a dose-dependent manner (Figure 2) . At a concentration of 0.1 g/mL, the inhibitory effect was only around 25%, but sharply increased to 62% at 1.0 g/mL, and almost reached a complete inhibitory effect at 25 g/mL. Up to now, it has been proven that ergosterol peroxide possesses a wide spectrum of biological activity [4b], such ascytotoxic activities against human gastric tumor (SNU-1), human hepatoma (SNU-354), human colorectal tumor (SNU-C4), and murine sarcoma-180 cell lines [4c], and suppression of HT29 and Hep3B cell growth [5a,b] ,as well as antioxidant [5c], antibacterial [5c] and Other effects on cells [4b,5d]. The mechanism of action is still unclear. While Takei [5e] proved that 25 M ergosterol peroxide induced apoptosis of HL60 cells, Xu [6a] reported cytotoxicity of the compound on MCF-7 at 20 M; Lee [6b] showed opposite results, reporting that ergosterol peroxide was inactive against HL-60 and MCF-7 cells, even at 100 g/mL (233 M).
Experimental
Fungal material: The fruiting body of Pleurotus eryngii (Dcex Fr.) Quél., industrial K-1 breed (Pleurotaceae), was obtained from Fukuda Food, Ogori,Fukuoka, Japan. Voucher specimen (E0001-2006) was deposited at the herbarium of Kyushu University, Japan.
Isolation of ergosterol peroxide: 1.5 Kg of fresh fruiting body of P. eryngii was dried using a freeze-dryer to afford 150 g of freezedried material, which was finely ground and extracted repeatedly (3 times) with 99.5% ethanol (7.5 L) at room temperature for 24 h. The extracts were filtered through Advantec No. 2 filter paper, concentrated under vacuum, and then freeze-dried to yield a residue of 5.4 g. A portion (5.3 g) was then re-dissolved in methanol (MeOH) and subjected to preparative HPLC eluting with MeOH (0.1% TFA), 5 mL/min, to give 6 fractions (Fr. 1 to Fr. 6). Fr. 3 (860 mg; obtained in a 20-45 min period of chromatography) was rechromatographed using preparative HPLC and eluted with methanol/water, 95:5, for 15 mins., and then methanol for 30 mins (5 mL/min) to give 9 fractions (Fr. 3-1 to Fr. [3] [4] [5] [6] [7] [8] [9] . Fr 3-4 (69 mg) was further subjected to HPLC using MeOH (0.1% TFA): H 2 O (0.1% TFA), 95: 5 as eluting solvent (10 mL/min, in 50 mins) to afford ergosterol peroxide (18 mg) [4a-c] .
Cell cultures: RAW264 cells were maintained in -MEM with 10% FBS. All media were supplemented with 2 mM glutamine, 100 IU/mL penicillin, and 100 mg/mL streptomycin. Incubations were performed at 37ºC in 5% CO 2 in humidified air. -MEM medium was also used for osteoclast generation and other experiments.
TRAP-positive cell staining:
The assay was that previously described [1d], with slight modification. In brief, RAW264 cells were suspended in phenol -MEM containing 10% FBS and plated at a concentration of 4.5×10 4 cells/mL into a 96-well culture dish. After 24 h of incubation, RANKL and TNF- were added into each well to obtain final concentrations of 40 ng/mL and 10 ng/mL, respectively. Then, different concentrations of samples dissolved in DMSO were added to the cultures. After 3 days of culturing, the cells were fixed and stained for TRAP using the TRAP staining kit, according to the manufacturer's instructions. TRAP stained cells with more than 3 nuclei were counted as osteoclasts. The medium contained 0.1% DMSO.
WST-1 assay: RAW264 cells were suspended in phenol -MEM containing 10% FBS and plated at a concentration of 4.5×10 4 cells/mL in a 96-well culture dish. After 24 h of incubation, RANKL and TNF-were added to each well to obtain final concentrations of 40 ng/mL and 10 ng/mL, respectively. Then, samples dissolved in DMSO with different concentrations were added to the cultures. After 3 days of culturing, the number of viable cells was compared by WST-1 [4-[3-(4-iodophenyl)-2-(4nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate] assay. Following incubation of cells for the above mentioned time, WST-1 and phenazine methosulfate (PMS) solutions were added to each well to obtain a final concentration of 0.5 mM, and samples were subsequently incubated at 37°C for 3 h. Following incubation, plates were slightly shaken and immediately read at 450 nm with a multi-well scanning spectrophotometer.
